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Abstract
The actions of the nitric oxide (NO) donors 1-hydroxy-2-oxo-3-(N-methyl-3-aminopropyl)-3 methyl-1-triazine (NOC-7),
S-nitrosoacetylcysteine (CySNO) and S-nitrosoglutathione (GSNO) on the purified calcium release channel (ryanodine
receptor) of rabbit skeletal muscle were determined by single channel current recordings. In addition, the activation of the
NO donor modulated calcium release channel by the sulfhydryl oxidizing organic mercurial compound 4-(chloromercu-
ri)phenylsulfonic acid (4-CMPS) was investigated. NOC-7 (0.1 and 0.3 mM) and CySNO (0.4 and 0.8 mM) increased the
open probability (Po) of the calcium release channel at activating calcium concentrations (20^100 WM Ca2) by 60^100%,
with no effect on the current amplitude; this activation was abolished by the specific sulfhydryl reducing agent DTT. High
concentrations of CySNO (1.6^2 mM) decreased Po. Activation by GSNO (1 mM) was observed in two thirds of the
experiments, but 2 mM and 4 mM GSNO markedly reduced Po at activating Ca2 (20^100 WM). In contrast to 4-CMPS,
NOC-7 or GSNO had no effect at subactivating free Ca2 (0.6 WM). 4-CMPS further increased the open probability of NOC-
7- or CySNO-stimulated channels and reversed transiently the reduced open probability of CySNO or GSNO inhibited
channels at activating free Ca2. High concentrations of GSNO did not prevent channel activation of 4-CMPS at
subactivating free Ca2. The NOC-7-, CySNO- or GSNO-modified channels were completely blocked by ruthenium red. It is
suggested that nitrosylation/oxidation of sulfhydryls by NO donors and oxidation of sulfhydryls by 4-CMPS affect different
cysteine residues essential in the gating of the calcium release channel. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Calcium release in skeletal muscle occurs via the
calcium release channel (ryanodine receptor) located
in the terminal cisternae of the sarcoplasmic reticu-
lum [1^3]. The skeletal muscle calcium release chan-
nel (RyR-1) is a homotetramer [4,5] and its activity is
regulated by various endogenous e¡ectors (calcium,
magnesium, ATP, calmodulin, FK-506-binding pro-
tein, sorcin, phosphorylation) and exogenous e¡ec-
tors [6^10]. Nitric oxide (NO) is produced in cardiac
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Abbreviations: HSR, heavy sarcoplasmic reticulum; HEPES,
N-2-hydroxyethylpiperazine-NP-2-ethanesulfonic acid; MOPS, 3-
(N-morpholino)propanesulfonic acid; EGTA, ethylene glycol-
bis(L-aminoethyl ether)-N,N,NP,NP-tetraacetic acid; CHAPS, 3-
[(cholamidopropyl)dimethylammonio]-1-propanesulfonate ; DTT,
1,4-dithiothreitol ; PMSF, phenylmethylsulfonyl £uoride; NOC-7,
[1-hydroxy-2-oxo-3-(N-methyl-3-aminopropyl)-3 methyl-1-tria-
zine] ; GSNO, S-nitrosoglutathione; CySNO, S-nitroso-N-acetyl-
cysteine; 4-CMPS, 4-(chloromercuri)phenylsulfonic acid; pCMB,
4-chloromercuribenzoic acid; SNAP, S-nitroso-N-acetylpenicill-
amine
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muscle and skeletal muscle physiologically [11,12].
Since calcium release from the sarcoplasmic reticu-
lum (HSR) initiates muscle contraction in skeletal
muscle [13^15] it has been postulated that endoge-
nous NO alters the contractile state possibly by af-
fecting the calcium release channel of sarcoplasmic
reticulum [11,12].
E¡ects of NO donor compounds on the calcium
release channel of sarcoplasmic reticulum of skeletal
muscle [16^18] and of cardiac muscle [19,20] have
been reported. Mezaros et al. [16] found a decrease
in the open probability (Po) with S-nitroso-N-acetyl-
penicillamine (SNAP) on the skeletal muscle calcium
release channel in HSR, whilst Stoyanovsky et al.
[17] reported an increase in Po with SNAP and
S-nitrosoacetylcysteine (CySNO) in single channel
recordings of skeletal muscle HSR vesicles. Aghadasi
et al. [18] postulated that NO donors have no acti-
vating e¡ect on the calcium release channel of skel-
etal muscle HSR at low concentrations, but pre-
vented oxidation of regulatory sulfhydryls, whilst
high concentrations of NO donors activated the cal-
cium release channel by producing intersubunit
cross-links. Xu et al. [20] demonstrated that S-nitro-
soacetylcysteine and S-nitrosoglutathione (GSNO)
activated the puri¢ed cardiac calcium release chan-
nel, which was associated with both nitrosylation
and oxidation of sulfhydryls of calcium release chan-
nel subunits. Alkylation or oxidation of sulfhydryls
of the calcium release channel had a marked e¡ect on
the activity of the calcium release channel [21,22].
Compounds such as 4-(chloromercuri)phenylsulfonic
acid (4-CMPS) [23,24], thimerosal [25,26] or the di-
hydrodipyridines 2,2-DTDP or 4,4-DTDP [26^28]
activated the calcium release channel at low concen-
trations whilst high concentrations inhibited the
channel.
The aim of the present investigation was to study
¢rstly the e¡ect of NO donors on the puri¢ed skeletal
muscle calcium release channel to exclude interfer-
ence with other proteins present in heavy sarcoplas-
mic reticulum fractions, and secondly to compare the
e¡ect of NO donors causing possibly nitrosylation
and oxidation of sulfhydryls of the calcium release
channel with those of 4-CMPS which only oxidizes
sulfhydryls.
This report demonstrates that NO donors are able
to activate and/or inhibit the puri¢ed skeletal muscle
calcium release channel, similarly as observed by
sulfhydryl oxidizing agents. However, activation or
inhibition of the calcium release channel by NO do-
nors is modi¢ed or reversed by 4-CMPS, indicating
that oxidation by 4-CMPS involves di¡erent reactive
sulfhydryls.
2. Materials and methods
2.1. Materials
GSNO, 4-CMPS, MOPS, HEPES, Tris, histidine,
CsCl (ultra pure), ruthenium red, N-acetyl-L-cysteine,
leupeptin, pepstatin, antipain, phenylmethylsulfonyl
£uoride were purchased from Sigma-Aldrich (Vien-
na, Austria); [3H]ryanodine from Dupont New Eng-
land Nuclear (Boston, MA, USA); ryanodine from
Agrisystems International (Wind Gap); NOC-7 from
Alexis (San Diego, CA, USA); phosphatidylserine,
phosphatidylethanolamine and phosphatidylcholine
from Avanti Polar Lipids (Alabaster, AL, USA);
Delrin bilayer chambers (CD22-200; CD13-200)
from Warner Instrument (Hamden, NJ, USA).
Aprotinin was a generous gift from Bayer Austria
(Vienna, Austria). L-S-Nitroso-N-acetylcysteine (Cy-
SNO) was synthesized from L-N-acetylcysteine and
NaNO2 according to Feelisch and Stamler [29]. Sep-
aration of CySNO from N-acetylcysteine was carried
out by reversed-phase HPLC on a LiChrospher 100
RP-18 column (C-18 column, 0.4U25 cm; Merck,
Darmstadt, Germany) with UV detection (L-4200
UV Vis detector; Merck) at 335 nm [30]; the mobile
phase consisted of 20% methanol and 30 mM phos-
phate bu¡er (pH 3.0). The retention time of CySNO
was 13.3 þ 0.06 min (means þ S.E.M; n = 28). NOC-7
was dissolved in 0.1 N NaOH. CySNO was kept in
20% methanol, 30 mM phosphate bu¡er and neu-
tralized with 2 M Tris immediately before use. All
other reagents were dissolved in MilliQ deionized
water.
2.2. Preparation of sarcoplasmic reticulum
Heavy sarcoplasmic reticulum vesicles (HSR) from
rabbit skeletal muscle were prepared as described
previously [24]. Brie£y, white back muscle (fast
twitch muscle) was homogenized in a Waring blender
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for 1.5 min in a medium containing 10 mM histidine
bu¡er (pH 7.0) and 100 mM NaCl, and centrifuged
for 35 min at 4000Ug. The supernatant was ¢ltered
through cheese cloth and centrifuged for 30 min at
30 000Ug. The pellet was resuspended in 10 mM
histidine bu¡er (pH 7.0), 0.6 M KCl, 250 mM su-
crose and centrifuged for 35 min at 100 000Ug. The
pellet was washed once in a medium containing
10 mM histidine bu¡er (pH 7.0), 100 mM NaCl,
200 mM sucrose, centrifuged again for 35 min at
100 000Ug and stored at 380‡C or used immediately
for the puri¢cation of the ryanodine receptor-calcium
release channel. All bu¡ers used for the preparation
and resuspension of HSR contained 0.5 Wg/ml leu-
peptin, 1 Wg/ml antipain, 1.4 Wg/ml aprotinin, 1 WM
pepstatin, 0.1 mM PMSF, 1 mM benzamidine.
2.3. Preparation of calcium release channel
(ryanodine receptor)
The calcium release channel of the terminal cister-
nae of sarcoplasmic reticulum vesicles was prepared
as described previously [24], a slight modi¢cation of
the preparation used previously [31]. Brie£y, heavy
sarcoplasmic reticulum vesicles from rabbit skeletal
muscle (prepared as above) were solubilized with
CHAPS (medium: 40 mM MOPS/Tris (pH 7.0),
1 M NaCl, 2 mM DTT, 1% CHAPS, 0.25% phos-
phatidylcholine, 0.5 Wg/ml leupeptin, 1 Wg/ml anti-
pain, 1.4 Wg/ml aprotinin, 1 WM pepstatin, 0.1 mM
PMSF, 1 mM benzamidine, 15 mg HSR/ml; incuba-
tion: 60 min at 3^4‡C), followed by centrifugation
twice for 35 min at 103 000Ug (Beckman 65 rotor).
The supernatant was centrifuged through a linear
7.5^20% sucrose gradient equilibrated in 40 mM
MOPS/Tris (pH 7.0), 300 mM NaCl, 2 mM DTT,
0.5% CHAPS, 0.25% phosphatidylcholine, 0.5 Wg/ml
leupeptin, 1 Wg/ml antipain, 1.4 Wg/ml aprotinin,
1 WM pepstatin, 0.1 mM PMSF, 1 mM benzamidine
for 14 h at 2‡C (Beckman SW28 rotor; 38 ml tubes).
Fractions containing the ryanodine receptor (deter-
mined by SDS-PAGE) were pooled and dialyzed for
24 h in a medium containing 40 mM MOPS/Tris (pH
7.0), 100 mM NaCl, 2 mM DTT, 0.15 mM CaCl2,
0.1 mM EGTA, 0.5 Wg/ml leupeptin, 1 Wg/ml anti-
pain, 1.4 Wg/ml aprotinin, 1 WM pepstatin, 0.1 mM
PMSF, 1 mM benzamidine. Sucrose (200 mM ¢nal
concentration) was added to the proteoliposomes be-
fore storage at 378‡C. Preparation and dialysis were
carried out at 2^4‡C.
2.4. SDS-polyacrylamide gel electrophoresis
(SDS-PAGE)
SDS-PAGE was performed in 5% polyacrylamide
gels (0.75 mm thickness) with 3% stacking gels as
described previously [31]. The puri¢ed ryanodine re-
ceptor was incubated with NOC-7 (0.3^0.6 mM),
HEPES/Tris (pH 7.4) for 30 min at 25‡C followed
by addition of 2% SDS, 10% glycerol, 10 mM Tris
(pH 6.8). Gels were run without a thiol reducing
agent, stained with 0.05% Coomassie blue in 10%
acetic acid. Molecular weight standards were run
on two separate lanes of the same gel: ferritin
(440 000), thyroglobulin (330 000), myosin (212 000).
2.5. Single channel recordings
Single channel recordings were carried out follow-
ing incorporation of puri¢ed calcium release chan-
nels (ryanodine receptors) into planar lipid bilayers,
essentially according to Coronado et al. [32] as de-
scribed previously [24,33]. Planar lipid bilayers were
formed from phosphatidylserine (10 mg/ml) and
phosphatidylethanolamine (10 mg/ml) in decane
(Avanti Polar Lipids). The lipid solution was spread
over a 200 Wm diameter aperture in a delrin cup
(Warner Instrument) separating two aqueous com-
partments. The cis bath solution (2.6 ml) and the
trans bath solution (4 ml) were connected to the
head stage input of a model EPC-9 ampli¢er (Heka
Elektronik, Lambrecht, Germany) via Ag/AgCl elec-
trodes and CsCl-agar bridges. The trans bath was
held at virtual ground. Cs was used as the charge
carrier through the calcium release channel to in-
crease the conductance of the channel [32]. The cis
solution was composed of 10 mM HEPES/Tris (pH
7.4), 480 mM CsCl, and 100 WM CaCl2 or 100 WM
CaCl2 plus 80 WM EGTA (free calcium 20 WM). The
trans solution was composed of 10 mM HEPES/Tris
(pH 7.4) and 50 mM CsCl, and in some experiments
additionally 100 WM CaCl2 or 100 WM CaCl2 plus
80 WM EGTA (free calcium 20 WM). In experiments
with NOC-7 (dissolved in 0.1 N NaOH) the HEPES/
Tris bu¡er was increased to 20 mM or 40 mM to
maintain the desired pH of 7.4. Unless stated other-
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wise, puri¢ed calcium release channels and other re-
agents were added to the cis chamber. Recordings
were ¢ltered at 4 kHz with a low-pass Bessel ¢lter,
digitized at 40 kHz and stored on the hard disc of a
McIntosh/PC. Single channel events were identi¢ed
using TAC V2.5 software (Skalar Instruments, Seat-
tle, WA, USA). Mean open probability (Po) of chan-
nels were identi¢ed by a 50% threshold analysis. The
lifetimes of open and closed events were determined
by the method of maximum likelihood (TACFit soft-
ware, Skalar Instruments).
2.6. [3H]Ryanodine binding
Test samples and controls were assayed in tripli-
cate for 90 min at 37‡C in 0.2 ml solution containing
20 mM MOPS/Tris (pH 7.0), 0.5 M CsCl, 100 WM
CaCl2, 0.1 mg HSR, 0.5 Wg/ml leupeptin, 1.4 Wg/ml
aprotinin, 0.1 mM PMSF and 10 nM [3H]ryanodine
[24]. Samples were ¢ltered on glass-¢ber ¢lters (pre-
soaked in 1% polyethylene imine) and washed with
10 ml of 20 mM MOPS/Tris (pH 7.0), 1 M NaCl;
non-speci¢c binding was measured in the presence of
100 WM unlabeled ryanodine as described previously
[24].
2.7. Protein assay
Protein was measured by the Folin method [34]
and in the presence of detergents plus phosphatidyl-
choline, according to Kaplan and Pedersen [35],
standardized against bovine serum albumin.
2.8. Calculations
Statistical analysis was carried out by t-test using
Sigmastat 2 software (Jandel, San Rafael, CA,
USA). Averaged results are presented as means þ
S.E.M.
3. Results
3.1. E¡ect of NOC-7 on the puri¢ed calcium release
channel at activating (20^100 WM) and
subactivating (0.6 WM) Ca2+ concentrations
An example of the activating e¡ect of NOC-7 on
the puri¢ed calcium release channel at 20 WM acti-
vating Ca2 is illustrated in Fig. 1. 0.1 mM and 0.3
mM NOC-7 added sequentially to the cis side (the
cytoplasmic side) increased the open probability con-
centration dependently (Fig. 1A^C, Table 1). Statis-
tical analysis of experiments with NOC-7 showed
that the open probability increased signi¢cantly
from 0.45 þ 0.03 (control, n = 9) to 0.62 þ 0.03
(0.1 mM NOC-7, n = 9) and to 0.72 þ 0.02 (0.3 mM
NOC-7; n = 6; means þ S.E.M; Table 1A). The chan-
nel activation by 0.3 mM NOC-7 was reversed by
addition of 8 mM DTT (Fig. 1D, Table 1B). Subse-
quent addition of 7 WM ruthenium red completely
closed the calcium release channel (Fig. 1E). In
four experiments 0.3 mM NOC-7 increased the
open probability from 0.40 þ 0.05 (control) to
0.72 þ 0.04 and was reduced to 0.47 þ 0.06 by 8 mM
or 16 mM DTT (n = 4; means þ S.E.M.; Table 1B),
which strongly indicates that the activating e¡ect of
the NO donor is due to a modulation of sulfhydryl
groups essential for the gating of the calcium release
channel. A series of control experiments were carried
out in the absence or presence of 2^16 mM DTT.
DTT had no signi¢cant e¡ect on Po compared to
controls (Table 2A), but 16 mM DTT reduced the
open probability about 18%. It is noted, however,
C
Fig. 1. Activation of single puri¢ed skeletal muscle calcium release channel by NOC-7 at 20 WM activating calcium and reversibility
by DTT. Single channel currents, shown as upward de£ections, were recorded at 0 mV holding potential with 480 mM/50 mM CsCl
(cis/trans). The baselines are indicated by the dotted lines. Control and test records (A^E) are from the same channel. Left panel : 400
ms sweeps. Right panel: ¢rst 40 ms of each 400 ms sweep. (A) Control: 20 WM Ca2, Po = 0.54. (B) 0.1 mM NOC-7 added to the cis
side, Po = 0.66 (4 min). (C) 0.3 mM NOC-7 added to the cis side, Po = 0.80 (5 min). (D) 8 mM DTT added to the cis side, Po = 0.51.
(E) 7 WM ruthenium red. Calibration bars represent 30 pA and 50 ms or 5 ms. Lifetime histograms of open times and channel open-
ing time constants (do) of control and of the same channel modi¢ed by 0.3 mM NOC-7 are displayed in F and G. The solid lines rep-
resent a ¢t according to three exponentials. Channel open probabilities (Po) and do were calculated from 45 600 events (control),
41 600 events (0.1 mM NOC-7), 46 900 events (0.3 mM NOC-7) and 25 600 (8 mM DTT).
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that 16 mM DTT increased the baseline noise indi-
cating that this high DTT concentration a¡ected the
lipid bilayer. For this reason [3H]ryanodine binding
to HSR in the absence or presence of the reducing
agent DTT was performed under equilibrium condi-
tions. [3H]Ryanodine binding to HSR in the presence
of 100 WM Ca2 (carried out with 10 nM
[3H]ryanodine and in the presence of 0.5 M CsCl
at 37‡C for 90 min) was not signi¢cantly changed
by 2^10 mM DTT (Table 2B). In three binding ex-
periments (37‡C, 30 min) 16 mM DTT reduced
[3H]ryanodine binding to HSR marginally by 11%.
Means of Po, current amplitudes and the distribu-
tion of the open and closed lifetimes of controls and
of the same channels modi¢ed by 0.3 mM NOC-7 in
six experiments are given in Table 3. The increase in
the open probability was associated with an increase
of the open lifetimes of the NOC-7-modi¢ed channel
(control: do1 = 0.27 þ 0.02 ms (86%); do2 = 0.67 þ 0.06
ms (14%); NOC-7: do1 = 0.17 þ 0.03 ms (20%);
do2 = 0.71 þ 0.07 ms (76%); do3 = 2.50 þ 0.42 ms
(4%), (Table 3, n = 6, means þ S.E.M.; see Fig.
1F,G). The current amplitude was not changed by
NOC-7 (Table 3).
Oxidation of sulfhydryls of the calcium release
channel by a sulfhydryl reacting organic mercurial
(4-CMPS) has two distinct e¡ects on the calcium
release channel. Low concentrations of 4-CMPS
(20 WM) cause a long lasting activation of the calci-
um release channel, whilst high concentrations
(100 WM) cause a rapid, but short lasting increase
in the open probability in single channel recordings
with the puri¢ed calcium release channel followed by
an inhibition of the channel [24]. As shown in Fig. 2
Table 2
E¡ect of DTT on single channel currents of the puri¢ed calci-
um release channel and [3H]ryanodine binding to HSR in the
presence of 100 WM activating Ca2 and 0.5 M CsCl
Open probability (n)
A
Control 0.55 þ 0.05 (7)
DTT 2 mM 0.57 þ 0.05 (7)ns
Control 0.54 þ 0.04 (7)
DTT 4 mM 0.49 þ 0.05 (7)ns
Control 0.47 þ 0.04 (7)
DTT 8 mM 0.42 þ 0.04 (7)ns
Control 0.44 þ 0.09 (4)
DTT 16 mM 0.36 þ 0.06 (4)ns
[3H]Ryanodine bound (% of control) (n)
B
DTT 2 mM 94.3 þ 3.1 (6)
DTT 4 mM 98.8 þ 2.3 (6)
DTT 8 mM 102.9 þ 3.0 (6)
DTT 10 mM 100.2 þ 2.5 (5)
(A) Single channel recordings with the puri¢ed calcium release
channel were performed in the absence or presence of 2^16
mM DTT. Single channel currents were recorded at 0 mV hold-
ing potential with 480 mM/50 mM CsCl (cis/trans). 100 WM
Ca2 cis was the sole activator. Control and test recordings are
from the same channel. nsNot signi¢cantly di¡erent from con-
trols. (B) [3H]Ryanodine binding to HSR in the absence or
presence of 2^10 mM DTT was carried out at 100 WM activat-
ing Ca2, 20 mM MOPS/Tris (pH 7.0), 0.5 M CsCl, 10 nM
[3H]ryanodine and 100 Wg/HSR in a volume of 0.2 ml (37‡C,
90 min). Values are given as % of controls ( þ S.E.M.) for the
number of experiments given in parentheses. [3H]Ryanodine
binding of controls was 4.33 þ 0.62 pmol/mg HSR (n = 6).
Table 1
Activation of single puri¢ed skeletal muscle calcium release
channels by NOC-7 at 20^100 WM activating Ca2 and reversi-
bility by DTT
Po n
A Control 0.45 þ 0.03 9
NOC-7 0.1 mM 0.62 þ 0.03a 9
NOC-7 0.3 mM 0.72 þ 0.02a 6
B Control 0.40 þ 0.05 4
NOC-7 0.3 mM 0.72 þ 0.04a 4
NOC-7 0.3 mM/8 or 16 mM
DTT
0.47 þ 0.06 4
C Control (100 WM Ca2) 0.442 þ 0.051 4
Control (0.6 WM Ca2) 0.017 þ 0.011 4
NOC-7 0.3 mM 0.003 þ 0.001 4
NOC-7 0.6 mM 0.007 þ 0.002 4
40^80 WM 4-CMPS 0.583 þ 0.098 3
Single channel currents were recorded at 0 mV holding poten-
tial with 480 mM/50 mM CsCl (cis/trans) in the presence of 20^
100 WM Ca2 (cis). Control and test records are from the same
channel. (A) Activation of single channel current by 0.1 mM
and 0.3 mM NOC-7. (B) Reversibility by 8 mM or 16 mM
DTT. (C) E¡ect of NOC-7 on single puri¢ed skeletal muscle
calcium release channels at subactivating Ca2 (0.6 WM). Single
channel recordings with the puri¢ed calcium release channel
performed at 0.6 WM Ca2 in the absence or presence of 0.3
mM and 0.6 mM NOC-7 followed by 40^80 WM 4-CMPS.
Channel open probabilities (Po) were calculated from 30 000^
50 000 events. Values are means þ S.E.M. for the number of ex-
periments given in parentheses.
aSigni¢cantly di¡erent from controls (P6 0.001). The half-life
time of NO release from NOC-7 is 10 min.
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the NOC-7-modi¢ed calcium release channel
(Po = 0.67; Fig. 2B) was markedly activated by
100 WM 4-CMPS (Po = 0.95; Fig. 2C) and then com-
pletely blocked.
To test for a possible activating e¡ect of NOC-7 at
low free calcium experiments with the puri¢ed calci-
um release channel were carried out at a free calcium
concentration of 0.6 WM as illustrated in Fig. 3.
Channel open probability (Po) of the control at
20 WM Ca2 was 0.57 (Fig. 3A). When the free cal-
cium concentration on the cis side of the bilayer was
reduced to 0.6 WM by addition of EGTA the calcium
release channel was predominantly closed
(Po = 0.002; Fig. 3B). Sequential addition of 0.3 mM
and 0.6 mM NOC-7 to the solution on the cis side
had no e¡ect on Po (Po = 0.001, Fig. 3C). However,
addition of 80 WM 4-CMPS caused a transient acti-
vation the calcium release channel in the presence of
0.6 mM NOC-7 (Po = 0.71, Fig. 3D). Statistical anal-
ysis of four experiments, carried out at low free cal-
cium of 0.6 WM, did not reveal any activating e¡ect
of NOC-7 at concentrations of 0.3 mM or 0.6 mM
(Table 1C). The open probability in the presence of
0.6 WM free calcium and 0.6 mM NOC-7 was
0.007 þ 0.002 (n = 4; means þ S.E.M.) and increased
to 0.58 þ 0.10 following addition of 40^80 WM 4-
CMPS (n = 3; means þ S.E.M.; Table 1C). The e¡ect
of 4-CMPS on the NOC-7-modi¢ed calcium release
channel was very similar to the data on activation
and inhibition of the puri¢ed calcium release channel
by 4-CMPS or pCMB reported previously [24]. How-
ever, activation of the NOC-7 modi¢ed calcium re-
lease channels required usually higher concentrations
of 4-CMPS and was followed by a complete closure
of the channel, whilst in controls high concentrations
of 4-CMPS caused a long lasting low activity state
following activation of the calcium release channel
[24].
3.2. E¡ect of CySNO on the puri¢ed calcium
release channel at activating (20^100 WM)
Ca2+ concentrations
An example of the activating e¡ect of CySNO on
the puri¢ed calcium release channel at an activating
calcium concentration of 60 WM is illustrated in Fig.
4. 0.4 mM and 0.8 mM CySNO added sequentially
to the cis side increased the open probability concen-
tration dependently (Fig. 4A^C). Statistical analysis
of experiments with CySNO showed that the open
probability increased signi¢cantly from 0.44 þ 0.03
(control, n = 11) to 0.61 þ 0.04 (0.4 mM CySNO,
n = 11) and to 0.74 þ 0.03 (0.8 mM CysNO; n = 6;
means þ S.E.M; Table 4A). The channel activation
by 0.8 mM CySNO was reversed by addition of
16 mM DTT (Fig. 4D), which strongly indicates
that the activating e¡ect of CySNO is due to a mod-
ulation of sulfhydryl groups essential for the gating
of the calcium release channel. In three experiments
0.8 mM CySNO increased the open probability from
Table 3
Mean open probability, mean current amplitude and mean open and closed lifetimes of controls and 0.3 mM NOC-7
Control (n = 6) 0.3 mM NOC-7 (n = 6)
Means þ S.E.M. Area (%) Means þ S.E.M. Area (%)
Po 0.43 þ 0.04 0.72 þ 0.02
Amplitude (pA) 22.4 þ 0.3 21.9 þ 0.4
Mean To (ms) 0.37 þ 0.04 0.73 þ 0.07
Mean Tc (ms) 0.47 þ 0.05 0.28 þ 0.02
do1 (ms) 0.27 þ 0.02 (86) 0.17 þ 0.03 (20)
do2 (ms) 0.67 þ 0.06 (14) 0.71 þ 0.07 (76)
do3 (ms) 2.50 þ 0.42 (4)
dc1 (ms) 0.39 þ 0.05 (88) 0.18 þ 0.01 (96)
dc2 (ms) 1.05 þ 0.22 (12) 1.04 þ 0.29 (4)
Channel open probabilities (Po), mean current amplitude (pA), mean channel open (To) and closed (Tc) duration (ms), cumulative
mean open and closed channel time constants (do, dc) and values of the percent of the channel represented by a time constant for pu-
ri¢ed calcium release channel activated by 20^100 WM cis Ca2 in the absence and presence of 0.3 mM NOC-7. Calcium release chan-
nels were recorded at 0 mV voltage holding potential with 480 mM/50 mM CsCl (cis/trans). Values are means þ S.E.M. from six chan-
nels included in the analysis.
BBAMCR 14524 3-9-99
J. Suko et al. / Biochimica et Biophysica Acta 1451 (1999) 271^287 277
0.48 þ 0.05 (control) to 0.75 þ 0.02 and was reduced
to 0.42 þ 0.08 by 16 mM DTT (n = 3; means
þ S.E.M.; Table 4B). Addition of 8 mM DTT to
calcium release channels activated by 0.8 mM Cy-
SNO did not reduce the increased open probability
in two of the three experiments. This ¢nding is sim-
ilar to the e¡ect of CySNO and DTT on the puri¢ed
cardiac calcium release channel; the activating e¡ect
of CySNO could not be reduced by 10 mM DTT
[20].
Means of Po, current amplitudes and the distribu-
tion of the open and closed lifetimes of controls and
of the same channels modi¢ed by 0.8 mM CySNO in
six experiments are given in Table 5. The increase in
the open probability was associated with an increase
of the open lifetimes of the CySNO-modi¢ed channel
(control: do1 = 0.28 þ 0.02 ms (81%); do2 = 0.64 þ 0.07
ms (19%); CySNO: do1 = 0.36 þ 0.05 ms (44%);
do2 = 1.05 þ 0.20 ms (55%); do3 = 4.55 þ 1.03 ms
(1%)) (Table 5, n = 6, means þ S.E.M.; see Fig.
Fig. 3. E¡ect of NOC-7 and 4-CMPS on single puri¢ed skeletal
muscle calcium release channels at low free calcium (0.6 WM).
Single channel currents, shown as upward de£ections, were re-
corded at 0 mV holding potential with 480 mM/50 mM CsCl
(cis/trans). The baselines are indicated by the dotted lines. Con-
trol and test records (A^D) are from the same channel. (A)
Control: 20 WM Ca2, Po = 0.57. (B) Control: 0.6 WM Ca2,
Po = 0.002. (C) 0.6 mM NOC-7, Po = 0.001. (D) Activation of
the channel by 40 WM 4-CMPS added to the cis side, Po = 0.71.
Calibration bars represent 30 pA and 5 ms.
Fig. 2. Activation of single puri¢ed skeletal muscle calcium re-
lease channel by NOC-7 and 4-CMPS at 100 WM activating
Ca2. Single channel currents, shown as upward de£ections,
were recorded at 0 mV holding potential with 480 mM/50 mM
CsCl (cis/trans). The baselines are indicated by the dotted lines.
Control and test records (A^C) are from the same channel. (A)
Control : 100 WM Ca2, Po = 0.46. (B) Activation by 0.1 mM
NOC-7 added to the cis side, Po = 0.67. (C) 100 WM 4-CMPS
added to the cis side induced a transient, maximum channel ac-
tivation followed by closure of the channel within 20 s. Calibra-
tion bars represent 30 pA and 5 ms.
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Fig. 4. Activation of single puri¢ed skeletal muscle calcium release channel by CySNO at 60 WM activating Ca2 and reversibility by
DTT. Single channel currents, shown as upward de£ections, were recorded at 0 mV holding potential with 480 mM/50 mM CsCl (cis/
trans). The baselines are indicated by the solid lines. Control and test records (A^D) are from the same channel. Left panel: 400 ms
sweeps. Right panel : ¢rst 40 ms of each 400 ms sweep. (A) Control : 60 WM Ca2, Po = 0.40. (B) 0.4 mM CySNO added to the cis
side, Po = 0.63 (7 min). (C) 0.8 mM CySNO added to the cis side, Po = 0.78 (5 min). (D) 16 mM DTT added to the cis side, Po = 0.29
(2 min). Calibration bars represent 30 pA and 50 ms or 5 ms. Lifetime histograms of open times and channel opening time constants
(do) of control and of the same channel modi¢ed by 0.8 mM CySNO are displayed in E and F. The solid lines represent a ¢t accord-
ing to three exponentials. Channel open probabilities (Po) and do were calculated from 45 900 events (control), 41 800 events (0.4 mM
CySNO), 39 600 events (0.8 mM CySNO) and 11 000 events (16 mM DTT).
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4E,F). The current amplitude was not changed by
CySNO (Table 5).
At high concentrations of CySNO (1.6^2.0 mM)
the activation by CySNO declined below control lev-
els, i.e. high concentrations of CySNO caused an
inhibition of the calcium release channel (Fig. 5).
This inhibition could not be reversed by 8 mM or
16 mM DTT (data not shown). However, when
80 WM 4-CMPS were added to the cis side solution
the CySNO-induced inhibition of the calcium release
channel was reversed and the channel was fully acti-
vated with an increase in the open probability from
0.28 to 0.94 (Fig. 5C,D). In three experiments with a
mean open probability of 0.38 þ 0.02 (control) and
activation of the calcium release channel to
0.60 þ 0.03 by 0.8 mM CySNO, a further addition
of 1.6^2.0 mM CySNO reduced Po to 0.24 þ 0.04;
addition of 20^80 WM 4-CMPS to the same channels
increased the open probability transiently to
0.86 þ 0.06 (means þ S.E.M., n = 3).
3.3. E¡ect of GSNO on the calcium release channel
at activating (20^100 WM) and subactivating
(0.6 WM) Ca2+ concentrations
An example of the e¡ects of 1 and 4 mM GSNO
on the puri¢ed calcium release channel at 20 WM
activating calcium is shown in Fig. 6. 1 mM
GSNO gave no straightforward e¡ect on the open
probability of the calcium release channel: activation
(Fig. 6), no e¡ect or inhibition of the calcium release
channel was observed. Activation of the calcium re-
lease channel was observed in ten of 17 experiments
(control: Po = 0.45 þ 0.04; 1 mM GSNO:
Po = 0.63 þ 0.06; n = 10, means þ S.E.M., Table 6).
In seven of 17 experiments 1 mM GSNO had either
no e¡ect or caused inhibition of the calcium release
channel. The mean values ( þ S.E.M.) for the open
probability in all experiments obtained in the absence
of GSNO (controls: Po = 0.48 þ 0.03; n = 17) and in
the presence of 1 mM GSNO from the same channels
Table 5
Mean open probability, mean current amplitude and mean open and closed lifetimes of controls and 0.8 mM CySNO
Control (n = 6) 0.8 mM CySNO (n = 6)
Means þ S.E.M. Area (%) Means þ S.E.M. Area (%)
Po 0.46 þ 0.04 0.74 þ 0.03
Amplitude (pA) 22.4 þ 1.2 21.8 þ 1.1
Mean To (ms) 0.41 þ 0.03 0.81 þ 0.11
Mean Tc (ms) 0.47 þ 0.05 0.27 þ 0.03
do1 (ms) 0.28 þ 0.02 (81) 0.36 þ 0.05 (44)
do2 (ms) 0.64 þ 0.07 (19) 1.05 þ 0.20 (55)
do3 (ms) 4.55 þ 1.03 (1)
dc1 (ms) 0.36 þ 0.04 (94) 0.18 þ 0.05 (96)
dc2 (ms) 1.47 þ 0.20 (6) 1.92 þ 0.93 (4)
Channel open probabilities (Po), mean current amplitude (pA), mean channel open (To) and closed (Tc) duration, cumulative mean
open and closed channel time constants (do, dc) and values of the percent of the channel represented by a time constant for puri¢ed
calcium release channel activated by 0.8 mM CySNO. Calcium release channels were recorded at 0 mV voltage holding potential with
480 mM/50 mM CsCl (cis/trans). Values are means þ S.E.M. from six channels included in the analysis.
Table 4
E¡ect of CySNO on single puri¢ed skeletal muscle calcium re-
lease channels at 20^100 WM activating Ca2 and reversibility
by DTT
Po n
A Control 0.44 þ 0.03 11
CySNO 0.4 mM 0.61 þ 0.04a 11
CySNO 0.8 mM 0.74 þ 0.03a 6
B Control 0.48 þ 0.05 3
CySNO 0.8 mM 0.75 þ 0.02a 3
CySNO 0.8 mM/16 mM DTT 0.42 þ 0.08 3
Single channel currents were recorded at 0 mV holding poten-
tial with 480 mM/50 mM CsCl (cis/trans) in the presence of 20^
100 WM Ca2 (cis). Control and test records are from the same
channel. (A) Activation of single channel current by 0.4 mM
and 0.8 mM CySNO. (B) Reversibility by 16 mM DTT. Chan-
nel open probabilities (Po) were calculated from 30 000^50 000
events. Values are means þ S.E.M. for the number of experi-
ments given in parentheses. aSigni¢cantly di¡erent from con-
trols (P6 0.001).
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(Po = 0.53 þ 0.05; n = 17) were not signi¢cantly di¡er-
ent (Table 6). However, GSNO concentrations of
2 mM and 4 mM (Fig. 6C) reduced the open prob-
ability. GSNO concentrations of 2 mM and 4 mM
caused a concentration dependent, signi¢cant reduc-
tion of Po. 2 mM GSNO reduced Po from 0.45 þ 0.03
(control; n = 11) to 0.18 þ 0.03 (n = 11) and 4 mM
GSNO reduced Po from 0.49 þ 0.03 (control;
n = 10) to 0.07 þ 0.02 (means þ S.E.M, n = 10) (Table
6). The distribution of the open and closed lifetimes
of the calcium release channel in the presence of
1 mM and 4 mM GSNO versus control are shown
in Fig. 6E^G.
Means of Po, current amplitudes and the distribu-
tion of the open and closed lifetimes of controls and
of the same channels modi¢ed by 4 mM GSNO in
eight experiments are given in Table 7. The decrease
in the open probability (control: 0.45 þ 0.04; 4 mM
GSNO: 0.051 þ 0.007) was associated with a decrease
in the frequency of channel £uctuations and a
marked increase in the closed lifetimes of the
GSNO modi¢ed channel and the best ¢t of the closed
lifetimes was obtained by three exponentials (con-
trol: dc1 = 0.36 þ 0.04 ms (93%); dc2 = 1.47 þ 0.50 ms
(7%); GSNO: dc1 = 0.61 þ 0.10 (20%), dc2 = 2.71 þ
0.12 ms (71%) and dc3 = 8.04 þ 1.02 ms (9%)) (Table
7, n = 8, means þ S.E.M.). The open lifetimes (con-
trol: do1 = 0.25 þ 0.17 ms (71%); do2 = 0.51 þ 0.06 ms
(29%); GSNO: do1 = 0.11 þ 0.01 ms (95%); do2 =
0.68 þ 0.11 ms (5%)) were reduced by 4 mM GSNO
(Table 7). The current amplitude was not a¡ected by
inhibitory concentrations of GSNO (Table 7).
The GSNO-induced inhibition was not changed by
addition of 8 mM or 16 mM DTT. However, when
20 WM 4-CMPS were added to the cis side of the
bathing solution the GSNO-induced inhibition of
the calcium release channel was reversed as shown
in Fig. 6: Po decreased from 0.48 (control) to 0.08 in
the presence of 4 mM GSNO and increased to 0.90
within 1.5 min after addition of 20 WM 4-CMPS to
the cis side followed by a complete inactivation of
the calcium release channel within 3 min. In experi-
ments carried out under conditions described in Fig.
6, the increase in the open probability by 20^40 WM
4-CMPS was associated with a marked increase in
the open lifetimes and the best ¢t was obtained by
three exponentials (do1 = 0.21 þ 0.05 ms (29%);
do2 = 1.41 þ 0.52 ms (51%); do3 = 7.08 þ 2.75 ms
(20%), Table 7, n = 4, means þ S.E.M.). The modula-
tion of the GSNO-inhibited channels by the organic
mercurial compound was similar to the data on acti-
vation of the puri¢ed calcium release channel by
4-CMPS or pCMB reported previously [24]. How-
ever, a higher concentration of 4-CMPS was required
for the activation of the GSNO-inhibited calcium
release channel (40 WM in three of four experiments)
as usually necessary in controls (absence of GSNO).
To test for a possible activating e¡ect of GSNO at
Fig. 5. Activation and inhibition of single puri¢ed skeletal
muscle calcium release channel by CySNO at 20 WM activating
Ca2 and reactivation by 4-CMPS. Single channel currents,
shown as upward de£ections, were recorded at 0 mV holding
potential with 480 mM/50 mM CsCl (cis/trans). The baselines
are indicated by the dotted lines. Control and test records (A^
D) are from the same channel. (A) Control : 20 WM Ca2,
Po = 0.35. (B) 0.8 mM CySNO added to the cis side, Po = 0.62
(5 min). (C) 1.6 mM CySNO added to the cis side reduced Po
to 0.28 (10 min). (D) 80 WM 4-CMPS added to the cis side,
Po = 0.94 (2 min). Channel open probabilities (Po) were calcu-
lated from 30 000 events (control), 30 000 events (0.8 mM Cy-
SNO), 38 000 events (1.6 mM CySNO) and 16 000 events
(80 WM 4-CMPS). Calibration bars represent 30 pA and 5 ms.
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low free calcium similar experiments as described
above were carried with the puri¢ed calcium release
channel at a free calcium concentration of 0.6 WM as
illustrated in Fig. 7. Channel open probability (Po)
of the control at 20 WM Ca2 was 0.54 (Fig. 7A).
When the free calcium concentration on the cis side
of the bilayer was reduced to 0.6 WM by addition of
EGTA the calcium release channel was predomi-
nantly closed (Po = 0.02; Fig. 7B). The addition of
1^4 mM GSNO to the solution on the cis side had
Fig. 6. Activation and inhibition of single puri¢ed skeletal muscle calcium release channels at 100 WM activating Ca2 by GSNO and
reactivation of the GSNO-inhibited channel by 4-CMPS. Single channel currents, shown as upward de£ections, were recorded at
0 mV holding potential with 480 mM/50 mM CsCl (cis/trans). The baselines are indicated by the solid lines. Control and test records
(A^D) are from the same channel. (A) Control: 100 WM Ca2, Po = 0.48. (B) Activation by 1 mM GSNO added to the cis side,
Po = 0.65 (5 min). (C) Inhibition by 4 mM GSNO added to the cis side, Po = 0.08 (9 min). (C) 20 WM 4-CMPS added to the cis side
induced a transient reactivation of the channel, Po = 0.90 (1 min) which was followed by closure of the channel. Calibration bars rep-
resent 30 pA and 5 ms. Lifetime histograms of open and closed times and channel opening and closed time constants (do, dc) of con-
trol and of the same channel modi¢ed by 0.1 mM and 4 mM GSNO are displayed in E^G. Channel open probabilities (Po) and d
were calculated from 22 700 events (control), 25 600 events (1 mM GSNO), 22 200 events (4 mM GSNO) and 10 400 (4 mM GSNO/20
WM 4-CMPS).
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little e¡ect on Po (Fig. 7C and 7D), whilst 20 WM
4-CMPS increased the open probability (Po = 0.38,
Fig. 7E). Statistical analysis of experiments carried
out at low free calcium of 0.6 WM did not reveal
any activating e¡ect of GSNO at concentrations of
1 mM to 4 mM (Table 8). However, 20^40 WM
4-CMPS activated the calcium release channel in
the presence of 4 mM GSNO. The open probability
in the presence of a low free calcium concentration
(0.6 WM) and 4 mM GSNO was 0.044 þ 0.017 (n = 6;
means þ S.E.M.) and increased to 0.62 þ 0.12 follow-
ing addition of 20^40 WM 4-CMPS (n = 3; means
þ S.E.M.; Table 8), i.e. even high concentrations of
GSNO did not prevent the activation of the calcium
release channel by 4-CMPS.
4. Discussion
The present study demonstrates a concentration-
dependent activation of the puri¢ed calcium release
channel of rabbit skeletal muscle by NOC-7 (Fig. 1,
Table 1) and CySNO (Fig. 4, Table 4) in the presence
of calcium as sole activator of the calcium release
channel. Both NO donors increased the open prob-
ability of single channel current £uctuations at 20^
100 WM activating Ca2 by 60^100%, without a¡ect-
ing the current amplitude. With GSNO an activating
e¡ect on the calcium release channel was seen only in
about two thirds of the experiments (ten from 17) at
a concentration of 1 mM (Fig. 6) whilst in seven of
17 experiments 1 mM GSNO had either no e¡ect or
a slight inhibitory e¡ect (Table 6). The reason for
these observations is not clear, but channels may
vary in their susceptibility to inhibitory concentra-
tions of GSNO. 2 mM GSNO decreased the open
probability of the calcium release channels by about
60% and 4 mM GSNO reduced the open probability
about one order of magnitude (Table 6). At high
concentrations of CySNO the activating e¡ect de-
clined and the open probability was reduced below
control values. No inhibitory e¡ect was observed
with NOC-7 at the tested concentrations up to
0.6 mM. Our ¢ndings with the puri¢ed calcium re-
lease channel are in good agreement with the re-
ported activation of the calcium release channel in
skeletal muscle HSR vesicles by CySNO [17] and
NOC-9 or NOC-15 [18].
Fig. 6 (continued).
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The increase in the open probability by NOC-7 or
CySNO at maximally activating calcium concentra-
tions (20^100 WM) was mainly due to an increase in
the mean open channel duration (Figs. 1 and 4). This
increase in the open channel duration was due to a
shift from short openings to longer openings of the
calcium release channel. The best ¢t of the open life-
times was obtained by three exponentials (Tables 3
and 5). The decrease in the open probability by Cy-
SNO or GSNO at activating calcium concentrations
was associated with a decrease in the frequency of
the channel openings, a decrease in the mean open
channel duration and a marked increase in the mean
closed channel duration (Table 7). The best ¢t of the
closed lifetimes in the presence of a high inhibitory
GSNO concentration was obtained by three expo-
nentials (Table 7). The tested NO donors had no
e¡ect on the current amplitude.
The mercaptide complex formed by binding of
4-CMPS to activating sulfhydryls of the calcium re-
lease channel was reversible in the presence of low
concentrations of the speci¢c thiol reducing agent
DTT [24], but high concentrations of DTT were re-
quired to reduce the NOC-7- or CySNO-induced in-
crease in the open probability close to control levels.
These ¢ndings suggest that the e¡ects of the tested
NO donors occurred, at least predominantly,
through modi¢cation of sulfhydryls of the calcium
release channel protein.
The mechanism responsible for the activation of
the puri¢ed skeletal muscle calcium release channel
by the tested NO donors NOC-7, CySNO and
GSNO may be due to nitrosylation/oxidation of sulf-
Table 7
Mean open probability, mean current amplitude and mean open and closed lifetimes of controls, 4 mM GSNO, 4 mM GSNO and
20^40 WM 4-CMPS
Control (n = 8) 4 mM GSNO (n = 8) 4 mM GSNO+20^40 WM 4-CMPS
(n = 4)
Means þ S.E.M. Area (%) Means þ S.E.M. Area (%) Means þ S.E.M. Area (%)
Po 0.45 þ 0.04 0.051 þ 0.007 0.79 þ 0.06
Amplitude (pA) 20.8 þ 0.4 19.4 þ 0.6 20.1 þ 0.4
Mean To (ms) 0.42 þ 0.04 0.15 þ 0.01 2.61 þ 1.38
Mean Tc (ms) 0.45 þ 0.05 3.56 þ 1.03 0.50 þ 0.14
do1 (ms) 0.25 þ 0.17 (71) 0.11 þ 0.01 (95) 0.21 þ 0.05 (29)
do2 (ms) 0.51 þ 0.06 (29) 0.68 þ 0.11 (5) 1.41 þ 0.52 (51)
do3 (ms) 7.08 þ 2.75 (20)
dc1 (ms) 0.36 þ 0.04 (93) 0.61 þ 0.10 (20) 0.12 þ 0.04 (95)
dc2 (ms) 1.47 þ 0.50 (7) 2.71 þ 0.12 (71) 3.72 þ 1.35 (5)
dc3 (ms) 8.04 þ 1.02 (9)
Channel open probabilities (Po), mean channel open (To) and closed (Tc) duration, cumulative mean open and closed channel time
constants (do, dc) and values of the percent of the channel represented by a time constant for puri¢ed calcium release channel acti-
vated by 20^100 WM cis Ca2 (n = 8), inhibited by 4 mM GSNO (n = 8) and reactivated by 20^40 WM 4-CMPS (n = 4). Calcium release
channels were recorded at 0 mV voltage holding potential with 480 mM/50 mM CsCl (cis/trans). Values are means þ S.E.M. for the
number of channels included in the analysis.
Table 6
E¡ect of GSNO on single puri¢ed skeletal muscle calcium re-
lease channels at 20^100 WM activating calcium
Po n
Control 0.45 þ 0.04 10
GSNO 1 mM 0.63 þ 0.06a 10
Control 0.48 þ 0.03 17
GSNO 1 mM 0.53 þ 0.05 17
Control 0.45 þ 0.03 11
GSNO 2 mM 0.18 þ 0.03b 11
Control 0.49 þ 0.03 10
GSNO 4 mM 0.07 þ 0.02b 10
Single channel recordings with the puri¢ed calcium release
channel were performed in the absence or presence of 1, 2 or
4 mM GSNO. Single channel currents were recorded at 0 mV
holding potential with 480 mM/50 mM CsCl (cis/trans) in the
presence of 20^100 WM Ca2 (cis). Control and test records are
from the same channel. Channel open probabilities (Po) were
calculated from 15 000^30 000 events. Values are mean-
s þ S.E.M. for the number of experiments given in parentheses.
Signi¢cantly di¡erent from controls: aP = 0.02, bP6 0.001.
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hydryls of cysteine residues essential for the gating of
the calcium release channel.
S-Nitrosylation or poly-S-nitrosylation of proteins
by NO donors has been shown [20,36]. For the pu-
ri¢ed cardiac calcium release channel it has been el-
egantly demonstrated that the activation of the chan-
nel by CySNO and GSNO was associated with
nitrosylation and oxidation of sulfhydryls of the cal-
cium release channel protein [20]. Nitrosylation and
oxidation of the calcium release channel were con-
centration-dependent and occurred simultaneously
[20].
The sulfhydryl oxidizing organic mercurial com-
pound 4-CMPS, which was used for comparison,
showed di¡erent e¡ects on the calcium release chan-
nel as observed in the presence of NO donors and, in
addition, 4-CMPS modi¢ed the NOC-7-, CySNO- or
GSNO-induced changes in the gating of the calcium
release channel. (i) Activation of the puri¢ed calcium
release channel by 4-CMPS was observed at subacti-
vating calcium concentrations [24]. NOC-7 (0.3 or
0.6 mM) or GSNO (1^4 mM) did not show any
activating e¡ect at a subactivating free calcium con-
centration of 0.6 WM. However, 4-CMPS activated
the calcium release channel in the presence 0.6 mM
NOC-7 or 4 mM GSNO (Fig. 3, Table 1C; Fig. 7,
Table 8). This ¢nding indicates that NOC-7 or
GSNO does not alter the calcium sensitivity of the
calcium release channel, whilst oxidation of sulfhy-
dryls of cysteine residues by 4-CMPS increased the
apparent calcium a⁄nity of the calcium release chan-
nel as described by us previously [24]. Alterations of
the apparent calcium a⁄nity of the calcium release
channel by the sulfhydryl oxidizing dithiodipyridines
(2,2P-DTDP, 4,4P-DTDP) have been shown [26,28].
(ii) The NOC-7-stimulated (Fig. 2) or CySNO-stimu-
lated calcium release channel was maximally acti-
vated by 4-CMPS (Po up to 0.95) in the presence
of 20^100 WM activating calcium, which could be
due to a 4-CMPS-induced oxidation of activating
sulfhydryl(s) of channel protein subunits [24]. Acti-
vation was followed by a complete closure of the
NOC-7-stimulated channels (Fig. 2). It has been pro-
posed previously that activation and inhibition of the
calcium release channel by 4-CMPS [24] or dihydro-
dipyridines [28] are due to oxidation of di¡erent sulf-
hydryls. (iii) 4-CMPS reversed the CySNO- or
GSNO-induced inhibition of the calcium release
channel at activating calcium concentrations (Figs.
5 and 7). Inhibitory concentrations of 4 mM
GSNO, which reduced Po by about one order of
magnitude, did not prevent the 4-CMPS-induced ac-
tivation of the calcium release channel (Fig. 7, Table
8). These marked di¡erences between NO donors
and the sulfhydryl oxidizing agent 4-CMPS in the
Fig. 7. E¡ect of GSNO and 4-CMPS on single puri¢ed skeletal
muscle calcium release channel at low free calcium (0.6 WM).
Single channel currents, shown as upward de£ections, were re-
corded at 0 mV holding potential with 480 mM/50 mM CsCl
(cis/trans). The baselines are indicated by the solid lines. Con-
trol and test records (A^E) are from the same channel. (A)
Control : 20 WM Ca2, Po = 0.54. (B) Control 0.6 WM Ca2,
Po = 0.02. (C) 1 mM GSNO added to the cis side (0.6 WM
Ca2), Po = 0.01. (D) 4 mM GSNO (0.6 WM Ca2), Po = 0.01.
(E) Activation of the channel by 20 WM 4-CMPS added to the
cis side, Po = 0.38. Calibration bars represent 30 pA and 50 ms.
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modi¢cation of the gating properties of the calcium
release channel (outlined above) suggest that di¡er-
ent sulfhydryls are involved in oxidation of the cal-
cium release channel by 4-CMPS and nitrosylation/
oxidation by NO donors assuming that NO donors
cause simultaneously nitrosylation/oxidation of the
skeletal muscle calcium release channel. Alterna-
tively, the 4-CMPS induced activation of the calcium
release channel prior inhibited by CySNO or GSNO
could be due to a de-nitrosylation of the calcium
release channel by 4-CMPS. To address this ques-
tion, three experiments have been carried out with
4-CMPS plus GSNO mixed for 1 min and added
simultaneously to the cis side giving a ¢nal concen-
tration of 20^40 WM 4-CMPS and 4 mM GSNO. In
all three experiments a transient increase in the open
probability was observed when 4-CMPS and GSNO
were added simultaneously, followed by an inhibition
of the channel activity and ¢nally a channel closure.
The open probability increased signi¢cantly from
0.50 þ 0.08 to 0.80 þ 0.02 (means þ S.E.M., n = 3;
P = 0.02). These results are not in favor of a de-nitro-
sylation of S-nitrosothiol(s) of the calcium release
channel during the 4-CMPS-induced activation of
GSNO inhibited channels (Fig. 6). On the other
hand, mixtures of 4-CMPS (40 WM^1.2 mM) with
4 mM GSNO kept for 30 s at room temperature
before separation of both agents by HPLC (under
conditions as described in Section 2 for CySNO iso-
lation) showed that the two compounds interact. The
4-CMPS peak and the GSNO peak of mixtures of
both were smaller than observed after separate injec-
tion of each compound. Furthermore, a new peak
appeared by injecting mixtures of 4-CMPS plus
GSNO, whose nature has not been identi¢ed, possi-
bly a glutathione-CMPS complex. These results
might partly explain the requirement of higher con-
centrations of 4-CMPS for channel activation in the
presence of NO donors and the transient nature of
the 4-CMPS-induced activation of the calcium re-
lease channel in the presence of high GSNO concen-
trations. The interaction between 4-CMPS and
GSNO observed in the HPLC experiments does not
rule out the possibility of a similar interaction be-
tween 4-CMPS and S-nitrosothiols of the calcium
release channel generated by GSNO.
Activation of the calcium release channel by reac-
tive oxygen species, such as H2O2, appears to a¡ect
sulfhydryls of cysteine residues di¡erently and to ox-
idize a third type or class of sulfhydryls [37]. H2O2
a¡ected sulfhydryls of the calcium release channel
from the luminal side and was able to reactivate
the 4-CMPS induced reduction in Po [37]. Further-
more, it was shown that the increase in the open
probability by H2O2 was associated with intersubunit
cross-links, which was reversed by DTT [38]. Inter-
estingly, NOC-9, NOC-15 and SNAP prevented
cross-linking of ryanodine receptor monomers by
sulfhydryl oxidation with diamide, but high concen-
trations of NOC-15 induced intersubunit cross-links
[18]. SDS-PAGE with the puri¢ed skeletal muscle
calcium release channel incubated with NOC-7 at
conditions similar to those used in the single channel
experiments did not show dimer formation or forma-
tion of greater protein complexes at concentrations
up to 0.6 mM. Intermolecular cross-links appear thus
less likely to explain the increase in the open proba-
bility by NOC-7 at concentrations used in the
present study; the formation of intramolecular
cross-links has not been excluded.
In conclusion, the data on single channel current
recordings with the puri¢ed skeletal muscle calcium
release channel show that NO donors activate and
inhibit the gating of the calcium release channel in
the presence of calcium as sole activator of the cal-
cium release channel. Activation of the calcium re-
lease channel was obtained by two classes of NO
Table 8
E¡ect of GSNO on single puri¢ed skeletal muscle calcium re-
lease channels at subactivating Ca2 (0.6 WM) and activation by
4-CMPS
Po n
Control (100 WM Ca) 0.62 þ 0.05 7
Control (0.6 WM Ca) 0.044 þ 0.014 7
GSNO 1 mM 0.058 þ 0.016 6
GSNO 2 mM 0.038 þ 0.015 5
GSNO 4 mM 0.044 þ 0.017 6
GSNO 4 mM/4-CMPS 20^40 WM 0.62 þ 0.12 3
Single channel recordings with the puri¢ed calcium release
channel were performed in the absence or presence of 1^4 mM
GSNO and 4 mM GSNO followed by 20^40 WM 4-CMPS at
0.6 WM Ca2. Single channel currents were recorded at 0 mV
holding potential with 480 mM/50 mM CsCl (cis/trans). Control
and test recordings are from the same channel. Values are
means þ S.E.M. for the number of experiments given in paren-
theses.
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donors (S-nitrosothiols, NONOate). Comparison of
the e¡ects of NO donors with the e¡ects of the sulf-
hydryl oxidizing compound 4-CMPS suggests that
nitrosylation/oxidation by NO donors involve di¡er-
ent sulfhydryls of cysteine residues of the calcium
release channel as oxidized by the organic mercurial
compound.
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